Horm Metab Res 1986; 18(6): 361-364
DOI: 10.1055/s-2007-1012317
ORIGINALS

© Georg Thieme Verlag, Stuttgart · New York

Effects of Parenteral Palatinose on Glucose Metabolism in Normal and Streptozotocin Diabetic Rats

Y. Okuda, K. Kawai, Y. Chiba, Y. Koide, K. Yamashita
  • Department of Internal Medicine, Institute of Clinical Medicine, University of Tsukuba, Sakura-mura, Niihari-gun, Japan
Further Information

Publication History

1985

1985

Publication Date:
14 March 2008 (online)

Summary

The present experiment was carried out to investigate the metabolism of palatinose (6-0-α-D-glucopyranosyl-D-fructose) in the rat. The bolus injection of palatinose (0.5 g/kg) in the tail vein of normal and Streptozotocin (STZ) diabetic rats caused significant increments in glucose and insulin concentrations. However, in severe STZ diabetic rats (> 300 mg/dl of fasting plasma glucose) no significant change in glucose and insulin concentrations was observed. In liver perfusion, the gradual decrease in glucose output from the normal and mild STZ diabetic rat livers perfused with 20 mM Krebs-Ringer-Tris buffer pH 7.4 was prevented by the addition of 5.5 mM palatinose in the perfusate and fructose was detected in the effluent during the palatinose infusion. The results indicate that palatinose is metabolized to glucose and fructose in both normal and diabetic rat tissues, and this causes the increase in blood glucose concentration. On the other hand, the direct stimulatory effect of insulin release from pancreatic B-cell was not observed when the palatinose was infused into the isolated perfused rat pancreas. The study suggest that palatinose administered parenterally is metabolized by tissues and expected to be used as a source of fluid and energy supply.